Jim Cramer Identifies Potential Buying Opportunity in VF Corporation After Earnings Dip Paul Tudor Jones Says No Chance Warsh Could Push Fed to Cut Rates BioOrbit Launches Drug Crystallization Technology on SpaceX to Space Station Targeting SelfInjected Cancer Treatments ATT CEO BlueCollar Workers Are Key to AI Economy Not College Graduates Meta Broadcom Among Tech Giants to Fund 125 Million Semiconductor Research Hub at UCLA Apple Faces Key AI Test at Upcoming WWDC as Stock Hovers Near Record Levels AERT Q1 2026 Earnings EPS Breaks into Positive Territory Stock Rallies RZC Q1 2026 Earnings Strong EPS Beat of 1417 Surprises Analysts EuroDry Ltd EDRY Q1 2026 Earnings EPS Misses Estimates by a Wide Margin as Costs Weigh Textron TXT Q1 2026 Earnings EPS Surpasses Estimates by 101 Revenue Details Unavailable Kyntra Bio Inc KYNB Q1 2026 Earnings PreRevenue Biotech Misses EPS Estimates as Stock Edges Higher WBD Q1 2026 Earnings NarrowerthanExpected Loss Amid Strategic Restructuring ENDRA Life Sciences NDRA Shows Modest Gains Testing Resistance at 573 Atmus Filtration ATMU Edges Higher as Stock Holds Near Support Eyes Resistance at 5273 HighTrend International Group HTCO Slips 4 as Selling Pressure Intensifies Forafric Global Warrants AFRIW Edge Higher as Price Tests Resistance Near 080 Stellar V Capital Corp Warrant SVCCW Holds Steady at 020 Amid Narrow Trading Range Berkshire Hathaway Boosts Airline and Tech Holdings Delta Stake and Alphabet Increase Duolingo Q1 2026 Earnings EPS Surges Past Estimates with 164 Beat AgEagle Aerial Systems UAVS Posts Modest Gain at 106 Resistance at 111 in Focus Xsolla SPAC 1 Units XSLLU Holds Steady at 998 Neutral Stance Ahead of Catalysts Electromed Inc ELMD Holds Steady Near Resistance as Traders Eye Key Levels Orchestra BioMed OBIO Edges Higher Navigating Key Support and Resistance Levels ST Bancorp STBA Holds Steady Near Support as Market Awaits Catalyst DHI Group Inc DHX Edges Higher Support Test Points to Potential Upside Incannex Healthcare IXHL Dips 327 as Stock Tests NearTerm Support Oramed Pharmaceuticals ORMP Drops 89 Support Level Under Pressure